Baudax Bio acquires biotechnology firm TeraImmune

Baudax Bio has acquired all outstanding equity interests of biotechnology firm TeraImmune in a stock-for-stock deal.

Jul 3, 2023 - 20:00

Baudax Bio acquires biotechnology firm TeraImmune

Baudax Bio has acquired all outstanding equity interests of biotechnology firm TeraImmune in a stock-for-stock deal.

Read the original article

Tags:

Previous Article

Camena bags $10m in funding from Mercia

Generative AI – beyond the hype

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

PRO-1107 by ProfoundBio Suzhou for Bladder Cancer: Like...

Apr 21, 2024

Type 2 diabetes prevention programs can work at large scale, study finds

Type 2 diabetes prevention programs can work at large s...

Nov 15, 2023

STAT+: DNA-sequencing giant Illumina slashes 2023 revenue projections

STAT+: DNA-sequencing giant Illumina slashes 2023 reven...

Aug 9, 2023